Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mendel

Showing results (91-100 of 116) with videos related to

Pageof 12
Sort By:
The Journal of Biological Chemistry|November 18, 1994
Conformational differences in human apolipoprotein B-100 among subspecies of low density lipoproteins (LDL). Association of altered proteolytic accessibility with decreased receptor binding of LDL subspecies from hypertriglyceridemic subjectsG C Chen, W Liu, P Duchateau, et al.
Obesity Research|August 10, 1999
Absence of cardiac valve dysfunction in obese patients treated with sibutramineD S Bach, A M Rissanen, C M Mendel, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1996
Effects of a 7-day treatment with a novel, orally active, growth hormone (GH) secretagogue, MK-677, on 24-hour GH profiles, insulin-like growth factor I, and adrenocortical function in normal young menG Copinschi, A Van Onderbergen, M L'Hermite-Balériaux, et al.
British Journal of Clinical Pharmacology|May 8, 1999
Pharmacokinetics and tolerability of oral rizatriptan in healthy male and female volunteersY Lee, J A Conroy, M E Stepanavage, et al.
Neuroendocrinology|February 12, 1998
Prolonged oral treatment with MK-677, a novel growth hormone secretagogue, improves sleep quality in manG Copinschi, R Leproult, A Van Onderbergen, et al.
The New England Journal of Medicine|September 9, 2014
Four-month moxifloxacin-based regimens for drug-sensitive tuberculosisStephen H Gillespie, Angela M Crook, Timothy D McHugh, et al.
Antimicrobial Agents and Chemotherapy|October 28, 2015
Contribution of Oxazolidinones to the Efficacy of Novel Regimens Containing Bedaquiline and Pretomanid in a Mouse Model of TuberculosisRokeya Tasneen, Fabrice Betoudji, Sandeep Tyagi, et al.
Cancer|March 12, 2008
Negative influence of changing biopsy practice patterns on the predictive value of prostate-specific antigen for cancer detection on prostate biopsyMichael J Schwartz, David H Hwang, Andrew J Hung, et al.
The Journal of Clinical Investigation|March 1, 1995
Familial ligand-defective apolipoprotein B. Identification of a new mutation that decreases LDL receptor binding affinityC R Pullinger, L K Hennessy, J E Chatterton, et al.
Journal of Human Hypertension|February 13, 2002
Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trialJ J Sramek, M T Leibowitz, S P Weinstein, et al.
Pageof 12

Showing results (91-100 of 116) with videos related to

Sort By:
Pageof 12
The Journal of Biological Chemistry|November 18, 1994
Conformational differences in human apolipoprotein B-100 among subspecies of low density lipoproteins (LDL). Association of altered proteolytic accessibility with decreased receptor binding of LDL subspecies from hypertriglyceridemic subjectsG C Chen, W Liu, P Duchateau, et al.
Obesity Research|August 10, 1999
Absence of cardiac valve dysfunction in obese patients treated with sibutramineD S Bach, A M Rissanen, C M Mendel, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1996
Effects of a 7-day treatment with a novel, orally active, growth hormone (GH) secretagogue, MK-677, on 24-hour GH profiles, insulin-like growth factor I, and adrenocortical function in normal young menG Copinschi, A Van Onderbergen, M L'Hermite-Balériaux, et al.
British Journal of Clinical Pharmacology|May 8, 1999
Pharmacokinetics and tolerability of oral rizatriptan in healthy male and female volunteersY Lee, J A Conroy, M E Stepanavage, et al.
Neuroendocrinology|February 12, 1998
Prolonged oral treatment with MK-677, a novel growth hormone secretagogue, improves sleep quality in manG Copinschi, R Leproult, A Van Onderbergen, et al.
The New England Journal of Medicine|September 9, 2014
Four-month moxifloxacin-based regimens for drug-sensitive tuberculosisStephen H Gillespie, Angela M Crook, Timothy D McHugh, et al.
Antimicrobial Agents and Chemotherapy|October 28, 2015
Contribution of Oxazolidinones to the Efficacy of Novel Regimens Containing Bedaquiline and Pretomanid in a Mouse Model of TuberculosisRokeya Tasneen, Fabrice Betoudji, Sandeep Tyagi, et al.
Cancer|March 12, 2008
Negative influence of changing biopsy practice patterns on the predictive value of prostate-specific antigen for cancer detection on prostate biopsyMichael J Schwartz, David H Hwang, Andrew J Hung, et al.
The Journal of Clinical Investigation|March 1, 1995
Familial ligand-defective apolipoprotein B. Identification of a new mutation that decreases LDL receptor binding affinityC R Pullinger, L K Hennessy, J E Chatterton, et al.
Journal of Human Hypertension|February 13, 2002
Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trialJ J Sramek, M T Leibowitz, S P Weinstein, et al.
Pageof 12